https://pmc.ncbi.nlm.nih.gov/articles/PMC12723595/
Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis - PMC
What are the long-term effects of early-start and placebo/delayed-start tofersen treatment in adults with SOD1 amyotrophic lateral sclerosis (ALS)? This...
amyotrophic lateral sclerosislong termtofersenpmc
https://pubmed.ncbi.nlm.nih.gov/38829431/
Long-term treatment of SOD1 ALS with tofersen: a multicentre experience in 17 patients
Clinical findings and NFL analysis strongly suggest that tofersen may have a disease-modifying effect in a subset of SOD1-ALS patients.
long term treatment
https://www.neurology.columbia.edu/news/als-fda-considering-approval-drug-tofersen-rare-form-disease
ALS: FDA Considering Approval of Drug Tofersen for Rare Form of Disease | Columbia Neurology
Apr 17, 2023 - Dr. Jinsy Andrews, associate professor of neurology at CUIMC, commented on the newly approved oral drug to treat amyotrophic lateral sclerosis (ALS), a nervous...